Skip to main content
. 2019 Jun 6;145(8):1999–2012. doi: 10.1007/s00432-019-02950-y

Fig. 6.

Fig. 6

CatK inhibitor has no effect on subcutaneous tumor growth in vivo. a Tumor volume was monitored twice weekly by caliper measurements. b Subcutaneous tumor sections were immunohistochemically stained with Ki67 antibody. c Quantified data were determined by the number of Ki67-positive cells dividing the total numbers into five randomly selected fields under light microscopy (× 400)